Canopy Growth targets European expansion and Canadian market growth

Canopy Growth is pivoting its strategy toward becoming a consumer cannabis business, focusing on medical cannabis expansion in Europe and strengthening its position in the Canadian recreational market. CEO Luc Mongeau stated that the company has implemented cost-cutting measures exceeding C$30 million and has refinanced its operations to support this shift.

Following the acquisition of MTL Cannabis, the company has risen to the sixth position in the Canadian recreational cannabis market, with a goal of reaching the top three. For the first quarter ending June 30, Canopy reported a net revenue of C$81.2 million, a 13% increase compared to the previous year.

The company also reported progress in profitability, with an adjusted EBITDA loss limited to C$3.2 million. This loss per share of C$0.03 outperformed consensus estimates of -C$0.06. The company reported a gross margin of 31% for the quarter.